focus -WSS

focus

author：leisure time 2025-09-28 03:36:39 - browse：93856

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Biotech startup Celsius cuts 75% of staff ahead of first trial start

entertainment

WSS

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Public health communication lessons from Covid

Alnylam reports growth in sales of rare disease treatments

A controversial new treatment promises to make little people taller

Alnylam reports growth in sales of rare disease treatments

focus

focus

focus

What does generative AI mean for health care? We asked experts

H.R. 3 is the wrong path to lower drug costs

Supreme Court strikes down use of affirmative action

Interest rates are at a 22

Apple is now the first public company to be valued at $3 trillion

A controversial new treatment promises to make little people taller

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Will biotech layoffs continue through 2023?

After affirmative action ruling, medical educators look to 'holistic review'

Late stage cancers on the rise after pandemic delayed screenings

leisure time

FDA approves Sage Therapeutics’ rapid

Group behind ProMed defends move to subscription

How to ethically and practically extend health care to all

Trump allegedly attempted to have surveillance video deleted: Special Counsel

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Personalized medicine goes far beyond genetics

leisure time

entertainment

entertainment

hotspot